$2.2901
-0.0499[-2.13%]
At close: Apr 24
$2.2901
0[0.00%]
After Hours: 6:21PM EDT
Omega Therapeutics
(NASDAQ:OMGA)Omega Therapeutics Stock (NASDAQ:OMGA), Analyst Ratings, Price Targets, Predictions
Omega Therapeutics Inc has a consensus price target of $12.14, established from looking at the 21 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, Chardan Capital, and Wedbush on April 3, 2024, April 1, 2024, and January 4, 2024. With an average price target of $9.33 between Piper Sandler, Chardan Capital, and Wedbush, there's an implied 307.55% upside for Omega Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Chardan Capital
Wedbush
HC Wainwright & Co.
JonesTrading
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Omega Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/03/2024 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 293% | Piper Sandler | Edward Tenthoff | $10 → $9 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 205.66% | Chardan Capital | Keay Nakae | $12 → $7 | Maintains | Buy | Get Alert |
| 01/04/2024 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 423.99% | Wedbush | Robert Driscoll | → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 423.99% | HC Wainwright & Co. | Robert Burns | $11 → $12 | Maintains | Buy | Get Alert |
| 11/10/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 423.99% | Wedbush | Robert Driscoll | $19 → $12 | Maintains | Outperform | Get Alert |
| 09/01/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 380.33% | HC Wainwright & Co. | Robert Burns | → $11 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 423.99% | Chardan Capital | Keay Nakae | → $12 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 380.33% | HC Wainwright & Co. | Robert Burns | → $11 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 423.99% | Chardan Capital | Keay Nakae | → $12 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 380.33% | HC Wainwright & Co. | Robert Burns | → $11 | Reiterates | → Buy | Get Alert |
| 03/24/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 380.33% | HC Wainwright & Co. | Robert Burns | → $11 | Reiterates | → Buy | Get Alert |
| 03/10/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 380.33% | JonesTrading | Catherine Novack | → $11 | Initiates | → Buy | Get Alert |
| 03/03/2023 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 336.66% | Piper Sandler | Edward Tenthoff | $8 → $10 | Maintains | Overweight | Get Alert |
| 12/08/2022 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 380.33% | HC Wainwright & Co. | Robert Burns | → $11 | Initiates | → Buy | Get Alert |
| 09/23/2022 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 423.99% | Chardan Capital | Keay Nakae | → $12 | Initiates | → Buy | Get Alert |
| 05/24/2022 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 74.66% | Goldman Sachs | Salveen Richter | $7 → $4 | Maintains | Neutral | Get Alert |
| 05/23/2022 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 205.66% | Piper Sandler | Edward Tenthoff | $30 → $7 | Maintains | Overweight | Get Alert |
| 08/24/2021 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 1471.98% | Wedbush | Robert Driscoll | — | Initiates | → Outperform | Get Alert |
| 08/24/2021 | OMGA | Buy Now | Omega Therapeutics | $2.29 | 1209.99% | Jefferies | Chris Howerton | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Omega Therapeutics (OMGA)?
The latest price target for Omega Therapeutics (NASDAQ: OMGA) was reported by Piper Sandler on April 3, 2024. The analyst firm set a price target for $9.00 expecting OMGA to rise to within 12 months (a possible 293.00% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Omega Therapeutics (OMGA)?
The latest analyst rating for Omega Therapeutics (NASDAQ: OMGA) was provided by Piper Sandler, and Omega Therapeutics reiterated their overweight rating.
When was the last upgrade for Omega Therapeutics (OMGA)?
There is no last upgrade for Omega Therapeutics.
When was the last downgrade for Omega Therapeutics (OMGA)?
There is no last downgrade for Omega Therapeutics.
When is the next analyst rating going to be posted or updated for Omega Therapeutics (OMGA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omega Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omega Therapeutics was filed on April 3, 2024 so you should expect the next rating to be made available sometime around April 3, 2025.
Is the Analyst Rating Omega Therapeutics (OMGA) correct?
While ratings are subjective and will change, the latest Omega Therapeutics (OMGA) rating was a reiterated with a price target of $10.00 to $9.00. The current price Omega Therapeutics (OMGA) is trading at is $2.29, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.